Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1997;75(9):1279–1283. doi: 10.1038/bjc.1997.217

Angiotensin II type 1 receptor expression in human breast tissues.

E R Inwang 1, J R Puddefoot 1, C L Brown 1, A W Goode 1, S Marsigliante 1, M M Ho 1, J G Payne 1, G P Vinson 1
PMCID: PMC2228240  PMID: 9155046

Abstract

We demonstrate the expression of angiotensin II type 1 (AT1) receptors in normal and diseased human breast tissues. Using monoclonal antibody 6313/G2, directed against a specific sequence in the extracellular domain of the AT1 receptor, immunocytochemical analysis revealed positive immunoreactivity in membrane and cytoplasm of specific cell types. Immunoblotting of solubilized proteins separated by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) from benign and malignant tumours identified a single immunoreactive species with a molecular mass of approximately 60 kDa, consistent with that of the mature glycosylated receptor. In studies of [125I]angiotensin II binding using breast membrane preparations, concentrations of specific angiotensin II binding sites were found to range from 1.8 to 100 fmol mg(-1) protein, with a K(d) of approximately 60 nM. Most of the specifically bound [125I]angiotensin II was displaced by losartan, a specific angiotensin II type 1 receptor antagonist, while less was displaced by the AT2 receptor type antagonist, CGP42112A, thus confirming the prevalence of AT1 receptors in this tissue type. These data suggest that the renin-angiotensin system may be involved in normal and abnormal breast tissue function.

Full text

PDF
1279

Images in this article

1280Figure 1
on p.1280
1281Figure 4
on p.1281

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barker S., Marchant W., Clark A. J., Jimenez E., Marsigliante S., Montiel M., Vinson G. P. Comparison of COS cell transfected AT1A and AT1B angiotensin II receptors and angiotensin II receptor isoforms in rat tissues using isoelectric focusing. Biochem Biophys Res Commun. 1993 Apr 30;192(2):392–398. doi: 10.1006/bbrc.1993.1428. [DOI] [PubMed] [Google Scholar]
  2. Barker S., Marchant W., Ho M. M., Puddefoot J. R., Hinson J. P., Clark A. J., Vinson G. P. A monoclonal antibody to a conserved sequence in the extracellular domain recognizes the angiotensin II AT1 receptor in mammalian target tissues. J Mol Endocrinol. 1993 Oct;11(2):241–245. doi: 10.1677/jme.0.0110241. [DOI] [PubMed] [Google Scholar]
  3. Capponi A. M., Catt K. J. Solubilization and characterization of adrenal and uterine angiotensin II receptors after photoaffinity labeling. J Biol Chem. 1980 Dec 25;255(24):12081–12086. [PubMed] [Google Scholar]
  4. Chen L. I., Prakash O. M., Ré R. N. The interaction of insulin and angiotensin II on the regulation of human neuroblastoma cell growth. Mol Chem Neuropathol. 1993 Jan-Feb;18(1-2):189–196. doi: 10.1007/BF03160033. [DOI] [PubMed] [Google Scholar]
  5. Desarnaud F., Marie J., Lombard C., Larguier R., Seyer R., Lorca T., Jard S., Bonnafous J. C. Deglycosylation and fragmentation of purified rat liver angiotensin II receptor: application to the mapping of hormone-binding domains. Biochem J. 1993 Jan 1;289(Pt 1):289–297. doi: 10.1042/bj2890289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dzau V. J. Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch Intern Med. 1993 Apr 26;153(8):937–942. [PubMed] [Google Scholar]
  7. Herblin W. F., Chiu A. T., McCall D. E., Ardecky R. J., Carini D. J., Duncia J. V., Pease L. J., Wong P. C., Wexler R. R., Johnson A. L. Angiotensin II receptor heterogeneity. Am J Hypertens. 1991 Apr;4(4 Pt 2):299S–302S. doi: 10.1093/ajh/4.4.299s. [DOI] [PubMed] [Google Scholar]
  8. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  9. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  10. Mendelsohn F. A., Quirion R., Saavedra J. M., Aguilera G., Catt K. J. Autoradiographic localization of angiotensin II receptors in rat brain. Proc Natl Acad Sci U S A. 1984 Mar;81(5):1575–1579. doi: 10.1073/pnas.81.5.1575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Noguchi S., Miyauchi K., Nishizawa Y., Sasaki Y., Imaoka S., Iwanaga T., Koyama H., Terasawa T. Augmentation of anticancer effect with angiotensin II in intraarterial infusion chemotherapy for breast carcinoma. Cancer. 1988 Aug 1;62(3):467–473. doi: 10.1002/1097-0142(19880801)62:3<467::aid-cncr2820620304>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  12. Okura T., Kitami Y., Wakamiya R., Marumoto K., Iwata T., Hiwada K. Renal and extra-renal renin gene expression in spontaneously hypertensive rats. Blood Press Suppl. 1992;3:6–11. [PubMed] [Google Scholar]
  13. Ouali R., Poulette S., Penhoat A., Saez J. M. Characterization and coupling of angiotensin-II receptor subtypes in cultured bovine adrenal fasciculata cells. J Steroid Biochem Mol Biol. 1992 Oct;43(4):271–280. doi: 10.1016/0960-0760(92)90161-b. [DOI] [PubMed] [Google Scholar]
  14. Peach M. J. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev. 1977 Apr;57(2):313–370. doi: 10.1152/physrev.1977.57.2.313. [DOI] [PubMed] [Google Scholar]
  15. Saridogan E., Djahanbakhch O., Puddefoot J. R., Demetroulis C., Collingwood K., Mehta J. G., Vinson G. P. Angiotensin II receptors and angiotensin II stimulation of ciliary activity in human fallopian tube. J Clin Endocrinol Metab. 1996 Jul;81(7):2719–2725. doi: 10.1210/jcem.81.7.8675601. [DOI] [PubMed] [Google Scholar]
  16. Saridogan E., Djahanbakhch O., Puddefoot J. R., Demetroulis C., Dawda R., Hall A. J., Vinson G. P. Type 1 angiotensin II receptors in human endometrium. Mol Hum Reprod. 1996 Sep;2(9):659–664. doi: 10.1093/molehr/2.9.659. [DOI] [PubMed] [Google Scholar]
  17. Sitzmann J. V., Wu Y., Cameron J. L. Altered angiotensin-II receptors in human hepatocellular and hepatic metastatic colon cancers. Ann Surg. 1994 May;219(5):500–507. doi: 10.1097/00000658-199405000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Trolliet M. R., Phillips M. I. The effect of chronic bilateral nephrectomy on plasma and brain angiotensin. J Hypertens. 1992 Jan;10(1):29–36. doi: 10.1097/00004872-199201000-00006. [DOI] [PubMed] [Google Scholar]
  19. Ullian M. E., Linas S. L. Role of receptor cycling in the regulation of angiotensin II surface receptor number and angiotensin II uptake in rat vascular smooth muscle cells. J Clin Invest. 1989 Sep;84(3):840–846. doi: 10.1172/JCI114244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Varela A. S., Bosco Lopez Saez J. J. Utility of serum activity of angiotensin-converting enzyme as a tumor marker. Oncology. 1993 Nov-Dec;50(6):430–435. doi: 10.1159/000227224. [DOI] [PubMed] [Google Scholar]
  21. Vinson G. P., Ho M. M., Puddefoot J. R. The distribution of angiotensin II type 1 receptors, and the tissue renin-angiotensin systems. Mol Med Today. 1995 Apr;1(1):35–39. doi: 10.1016/1357-4310(95)80018-2. [DOI] [PubMed] [Google Scholar]
  22. Wang Y., Yamaguchi T., Franco-Saenz R., Mulrow P. J. Regulation of renin gene expression in rat adrenal zona glomerulosa cells. Hypertension. 1992 Dec;20(6):776–781. doi: 10.1161/01.hyp.20.6.776. [DOI] [PubMed] [Google Scholar]
  23. Whitebread S., Mele M., Kamber B., de Gasparo M. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun. 1989 Aug 30;163(1):284–291. doi: 10.1016/0006-291x(89)92133-5. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES